Enfermedades infecciosas y microbiología clínica
-
Enferm. Infecc. Microbiol. Clin. · Nov 2013
[Eradication of a nosocomial outbreak of multidrug-resistant Acinetobacter baumannii infections after adjusting nursing workloads and reinforcing specific precautions].
During 2009, an outbreak of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) infections was detected in a 27-bed intensive care unit, resulting in 25 cases being infected. ⋯ The results suggest patient-to-patient transmission of MDR A. baumannii. Reinforcement of specific procedures and work load adjustment were essential to eradicate this outbreak.
-
Enferm. Infecc. Microbiol. Clin. · Oct 2013
Review Practice GuidelineManagement of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).
Solid organ transplant (SOT) recipients are at greater risk than the general population for complications and mortality from influenza infection. ⋯ The latest scientific information available regarding influenza infection in the context of SOT is incorporated into this document.
-
Enferm. Infecc. Microbiol. Clin. · Oct 2013
[Antibiotic ointments and methicillin-resistant Staphylococcus aureus with a reservoir in a healthcare worker in a tertiary hospital].
Methicillin-resistant Staphylococcus aureus (MRSA) has become an important hospital-acquired pathogen, with transfer of the organism from a carrier or infected patient to uninfected patients by the hands or clothing of staff as the main mode of transmission. ⋯ This report illustrates the risk of nosocomial transmission linked to care delivered by healthcare workers.
-
Enferm. Infecc. Microbiol. Clin. · Dec 2012
[Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
Enzyme linked fluorescent assays (VIDAS EBV VCA IgM, VIDAS EBV VCA/EA IgG and VIDAS EBV EBNA IgG (Biomérieux, France) were evaluated to determine markers for infection of Epstein Barr virus, as well as to establish antibody profiles, compared with immunofluorescence assays as reference. The assays evaluated showed good values for sensitivity, specificity and agreement, making them useful for their application in clinical laboratories.